Sequence of CP2C9_HUMAN

(R)-limonene 6-monooxygenase

P11712

490

55628

1172129

Meehan R.R.,Gosden J.R.,Rout D.,Hastie N.D.,Friedberg T.,Adesnik M.,Buckland R.,van Heyningen V.,Fletcher J.M.,Spurr N.K.,Sweeney J.,Wolf C.R.

Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10.

Am. J. Hum. Genet.

42

26-37

1988

1172130

Kimura S.,Pastewka J.,Gelboin H.V.,Gonzalez F.J.

cDNA and amino acid sequences of two members of the human P450IIC gene subfamily.

Nucleic Acids Res.

15

10053-10054

1987

1172132

Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.

Complete sequencing and characterization of 21,243 full-length human cDNAs.

Nat. Genet.

36

40-45

2004

1172133

Deloukas P.,Earthrowl M.E.,Grafham D.V.,Rubenfield M.,French L.,Steward C.A.,Sims S.K.,Jones M.C.,Searle S.,Scott C.,Howe K.,Hunt S.E.,Andrews T.D.,Gilbert J.G.R.,Swarbreck D.,Ashurst J.L.,Taylor A.,Battles J.,Bird C.P.,Ainscough R.,Almeida J.P.,Ashwell R.I.S.,Ambrose K.D.,Babbage A.K.,Bagguley C.L.,Bailey J.,Banerjee R.,Bates K.,Beasley H.,Bray-Allen S.,Brown A.J.,Brown J.Y.,Burford D.C.,Burrill W.,Burton J.,Cahill P.,Camire D.,Carter N.P.,Chapman J.C.,Clark S.Y.,Clarke G.,Clee C.M.,Clegg S.,Corby N.,Coulson A.,Dhami P.,Dutta I.,Dunn M.,Faulkner L.,Frankish A.,Frankland J.A.,Garner P.,Garnett J.,Gribble S.,Griffiths C.,Grocock R.,Gustafson E.,Hammond S.,Harley J.L.,Hart E.,Heath P.D.,Ho T.P.,Hopkins B.,Horne J.,Howden P.J.,Huckle E.,Hynds C.,Johnson C.,Johnson D.,Kana A.,Kay M.,Kimberley A.M.,Kershaw J.K.,Kokkinaki M.,Laird G.K.,Lawlor S.,Lee H.M.,Leongamornlert D.A.,Laird G.,Lloyd C.,Lloyd D.M.,Loveland J.,Lovell J.,McLaren S.,McLay K.E.,McMurray A.,Mashreghi-Mohammadi M.,Matthews L.,Milne S.,Nickerson T.,Nguyen M.,Overton-Larty E.,Palmer S.A.,Pearce A.V.,Peck A.I.,Pelan S.,Phillimore B.,Porter K.,Rice C.M.,Rogosin A.,Ross M.T.,Sarafidou T.,Sehra H.K.,Shownkeen R.,Skuce C.D.,Smith M.,Standring L.,Sycamore N.,Tester J.,Thorpe A.,Torcasso W.,Tracey A.,Tromans A.,Tsolas J.,Wall M.,Walsh J.,Wang H.,Weinstock K.,West A.P.,Willey D.L.,Whitehead S.L.,Wilming L.,Wray P.W.,Young L.,Chen Y.,Lovering R.C.,Moschonas N.K.,Siebert R.,Fechtel K.,Bentley D.,Durbin R.M.,Hubbard T.,Doucette-Stamm L.,Beck S.,Smith D.R.,Rogers J.

The DNA sequence and comparative analysis of human chromosome 10.

Nature

429

375-381

2004

1172135

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Genome Res.

14

2121-2127

2004

1172136

Yasumori T.,Kawano S.,Nagata K.,Shimada M.,Yamazoe Y.,Kato R.

Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form.

J. Biochem.

102

1075-1082

1987

1172137

Umbenhauer D.R.,Martin M.V.,Lloyd R.S.,Guengerich F.P.

Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase.

Biochemistry

26

1094-1099

1987

1172138

Ged C.,Umbenhauer D.R.,Bellew T.M.,Bork R.W.,Srivastava P.K.,Shinriki N.,Lloyd R.S.,Guengerich F.P.

Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.

Biochemistry

27

6929-6940

1988

1172139

Ohgiya S.,Komori M.,Ohi H.,Shiramatsu K.,Shinriki N.,Kamataki T.

Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity.

Biochem. Int.

27

1073-1081

1992

1172140

Shimada T.,Misono K.S.,Guengerich F.P.

Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.

J. Biol. Chem.

261

909-921

1986

1172141

Komori M.,Hashizume T.,Ohi H.,Miura T.,Kitada M.,Nagashima K.,Kamataki T.

Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization.

J. Biochem.

104

912-916

1988

1172142

Srivastava P.K.,Yun C.H.,Beaune P.H.,Ged C.,Guengerich F.P.

Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.

Mol. Pharmacol.

40

69-79

1991

1172143

Haining R.L.,Hunter A.P.,Veronese M.E.,Trager W.F.,Rettie A.E.

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

Arch. Biochem. Biophys.

333

447-458

1996

1172144

Sandhu P.,Baba T.,Guengerich F.P.

Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.

Arch. Biochem. Biophys.

306

443-450

1993

1172145

Zeldin D.C.,DuBois R.N.,Falck J.R.,Capdevila J.H.

Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.

Arch. Biochem. Biophys.

322

76-86

1995

1172146

Bylund J.,Ericsson J.,Oliw E.H.

Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS.

Anal. Biochem.

265

55-68

1998

1172147

Bylund J.,Kunz T.,Valmsen K.,Oliw E.H.

Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes.

J. Pharmacol. Exp. Ther.

284

51-60

1998

1172148

Miyazawa M.,Shindo M.,Shimada T.

Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.

Drug Metab. Dispos.

30

602-607

2002

1172149

Lee A.J.,Cai M.X.,Thomas P.E.,Conney A.H.,Zhu B.T.

Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.

Endocrinology

144

3382-3398

2003

1172150

Barbosa-Sicard E.,Markovic M.,Honeck H.,Christ B.,Muller D.N.,Schunck W.H.

Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.

Biochem. Biophys. Res. Commun.

329

1275-1281

2005

1172151

Lucas D.,Goulitquer S.,Marienhagen J.,Fer M.,Dreano Y.,Schwaneberg U.,Amet Y.,Corcos L.

Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.

J. Lipid Res.

51

1125-1133

2010

1172152

Honda A.,Miyazaki T.,Ikegami T.,Iwamoto J.,Maeda T.,Hirayama T.,Saito Y.,Teramoto T.,Matsuzaki Y.

Cholesterol 25-hydroxylation activity of CYP3A.

J. Lipid Res.

52

1509-1516

2011

1172153

Bian Y.,Song C.,Cheng K.,Dong M.,Wang F.,Huang J.,Sun D.,Wang L.,Ye M.,Zou H.

An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

J. Proteomics

96

253-262

2014

1172154

Williams P.A.,Cosme J.,Ward A.,Angove H.C.,Matak-Vinkovic D.,Jhoti H.

Crystal structure of human cytochrome P450 2C9 with bound warfarin.

Nature

424

464-468

2003

1172155

Stubbins M.J.,Harries L.W.,Smith G.,Tarbit M.H.,Wolf C.R.

Genetic analysis of the human cytochrome P450 CYP2C9 locus.

Pharmacogenetics

6

429-439

1996

1172156

Bhasker C.R.,Miners J.O.,Coulter S.,Birkett D.J.

Allelic and functional variability of cytochrome P4502C9.

Pharmacogenetics

7

51-58

1997

1172157

Imai J.,Ieiri I.,Mamiya K.,Miyahara S.,Furuumi H.,Nanba E.,Yamane M.,Fukumaki Y.,Ninomiya H.,Tashiro N.,Otsubo K.,Higuchi S.

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.

Pharmacogenetics

10

85-89

2000

1172158

Dickmann L.J.,Rettie A.E.,Kneller M.B.,Kim R.B.,Wood A.J.,Stein C.M.,Wilkinson G.R.,Schwarz U.I.

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans.

Mol. Pharmacol.

60

382-387

2001

1172159

Higashi M.K.,Veenstra D.L.,Kondo L.M.,Wittkowsky A.K.,Srinouanprachanh S.L.,Farin F.M.,Rettie A.E.

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

JAMA

287

1690-1698

2002

1172160

Solus J.F.,Arietta B.J.,Harris J.R.,Sexton D.P.,Steward J.Q.,McMunn C.,Ihrie P.,Mehall J.M.,Edwards T.L.,Dawson E.P.

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.

Pharmacogenomics

5

895-931

2004

1172161

Ciccacci C.,Falconi M.,Paolillo N.,Oteri F.,Forte V.,Novelli G.,Desideri A.,Borgiani P.

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.

Pharmacogenet. Genomics

21

344-346

2011

1172162

Nahar R.,Dube D.,Parakh R.,Deb R.,Saxena R.,Singh T.P.,Verma I.C.

Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity.

Thromb. Res.

131

535-539

2013

1172163

Lee Y.M.,Eggen J.,Soni V.,Drozda K.,Nutescu E.A.,Cavallari L.H.

Warfarin dose requirements in a patient with the CYP2C9*14 allele.

Pharmacogenomics

15

909-914

2014

1172164

Dai D.P.,Wang S.H.,Li C.B.,Geng P.W.,Cai J.,Wang H.,Hu G.X.,Cai J.P.

Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.

Drug Metab. Dispos.

43

1246-1249

2015